Augery-Bourget Y - Search Results

1

A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization.

Krief P, Augery-Bourget Y, Plaisance S, Merck MF, Assier E, Tanchou V, Billard M, Boucheix C, Jasmin C, Azzarone B. Krief P, et al. Among authors: augery bourget y. Oncogene. 1994 Dec;9(12):3449-56. Oncogene. 1994. PMID: 7970704

2

Expression of the interleukin-2 receptor on human fibroblasts and its biological significance.

Plaisance S, Rubinstein E, Alileche A, Sahraoui Y, Krief P, Augery-Bourget Y, Jasmin C, Suarez H, Azzarone B. Plaisance S, et al. Among authors: augery bourget y. Int Immunol. 1992 Jul;4(7):739-46. doi: 10.1093/intimm/4.7.739. Int Immunol. 1992. PMID: 1379826

3

N-ras dependent revertant phenotype in human HT1080 fibrosarcoma cells is associated with loss of proliferation within normal tissues and expression of an adult membrane antigenic phenotype.

Carloni G, Paterson H, Mareel M, Augery-Bourget Y, Sahraoui J, Rubinstein E, Suarez H, Azzarone B. Carloni G, et al. Oncogene. 1989 Jul;4(7):873-80. Oncogene. 1989. PMID: 2666908

4

Presence of a p70 IL-2-binding peptide on leukemic cells from various hemopoietic lineages.

Allouche M, Sahraoui Y, Augery-Bourget Y, Ohashi Y, Sugamura K, Jasmin C, Georgoulias V. Allouche M, et al. Among authors: augery bourget y. J Immunol. 1989 Oct 1;143(7):2223-9. J Immunol. 1989. PMID: 2789258

5

Phorbol myristate acetate induces both high affinity and low affinity interleukin 2-receptors on a pre-B leukemic cell line.

Allouche M, Georgoulias V, Augery-Bourget Y, Sahraoui Y, Tsapis A, Perraki M, Clemenceau C, Choulakis V, Jasmin C. Allouche M, et al. Among authors: augery bourget y. Leuk Res. 1990;14(4):353-61. doi: 10.1016/0145-2126(90)90163-4. Leuk Res. 1990. PMID: 2332988

6

Interleukin 2 receptors.

Allouche M, Sahraoui Y, Augery-Bourget Y, Perrakis M, Jasmin C, Georgoulias V. Allouche M, et al. Among authors: augery bourget y. Leuk Res. 1990;14(8):699-703. doi: 10.1016/0145-2126(90)90097-s. Leuk Res. 1990. PMID: 2201821 Review.

7

Impaired in-vitro proliferation of hemopoietic precursors in HIV-1-infected subjects.

Lunardi-Iskandar Y, Georgoulias V, Bertoli AM, Augery-Bourget Y, Ammar A, Vittecoq D, Rosenbaum W, Meyer P, Jasmin C. Lunardi-Iskandar Y, et al. Leuk Res. 1989;13(7):573-81. doi: 10.1016/0145-2126(89)90124-0. Leuk Res. 1989. PMID: 2668646

8

c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells.

Francastel C, Augery-Bourget Y, Prenant M, Walters M, Martin DI, Robert-Lézénès J. Francastel C, et al. Among authors: augery bourget y. Oncogene. 1997 Feb 20;14(7):873-7. doi: 10.1038/sj.onc.1200902. Oncogene. 1997. PMID: 9047395

9

NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity.

Francastel C, Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J. Francastel C, et al. Among authors: augery bourget y. Leukemia. 1997 Feb;11(2):273-80. doi: 10.1038/sj.leu.2400552. Leukemia. 1997. PMID: 9009092

10

C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.

Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J. Poindessous-Jazat V, et al. Among authors: augery bourget y. Leukemia. 2002 Feb;16(2):233-43. doi: 10.1038/sj.leu.2402350. Leukemia. 2002. PMID: 11840290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters